Updated:
PiSA BioPharm
PiSA BioPharm specializes in products for health system pharmacies, drug compounders, vascular access professionals, and veterinarians in the US, Canada, and...
PiSA BioPharm
PiSA BioPharm specializes in products for health system pharmacies, drug compounders, vascular access professionals, and veterinarians in the US, Canada, and Europe. Its focus is on the highly regulated markets of these regions. The company addresses specific needs in these areas.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Boston
Corporate office
Boston, MA, United States
Additional offices
Mount Pleasant · New York · Albany
Sector focus
Frequently asked questions
What does PiSA BioPharm do?
PiSA BioPharm is a biopharmaceutical company based in Boston, Massachusetts, with additional locations in Mount Pleasant, New York, and Albany, New York. Public records indicate a focus on pharmaceutical development and commercialization, though specific product areas or pipeline details are not disclosed.
Who runs PiSA BioPharm?
The names of principals or leadership are not publicly listed in any sourced documents. The firm's website (per pisa-biopharm.com) does not publish a team or management section, and no other identifiable records exist.
Is PiSA BioPharm a family office or a traditional pharmaceutical company?
PiSA BioPharm is classified here as 'other' due to insufficient data. Its name and locations suggest a biopharma operating company rather than a family office or investment vehicle, but no ownership or governance structure is confirmed.
Does PiSA BioPharm disclose its financials?
No. There are no public filings, AUM figures, or deployment statements attributable to PiSA BioPharm. The firm does not appear in major databases or news outlets.
Where is PiSA BioPharm located?
Headquarters are in Boston, Massachusetts. Additional offices are listed in Mount Pleasant, New York; New York City; and Albany, New York (per the firm's website).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: